Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Hospitals

 

EMEA hospital sector finishes 2020 strongly

Private hospital operators across Europe, the Middle East and South Africa had a good last few months of trading in what was a turbulent 2020, but the start of 2021 looks tougher. We talk to operators across the region.

Carlyle to exit Ameos in H2

Private equity firm Carlyle will exit German and Swiss acute/psychiatric hospital operator Ameos Group in the second half of this year, a spokesperson for Ameos tells HBI. Reports say that CEO Dr Axel Paeger and London-listed Intermediate Capital Group (ICG) will become controlling shareholders.

Ameos sale/refinancing: Speculation mounts as group denies discussions

Despite emphatic denials from the company itself that it is for sale, multiple sources continue to tell HBI that DACH psychiatry and acute hospital group Ameos is in discussion with potential suitors and that documentation preparing for refinancing and/or sale has been drawn up. HBI speaks to an operator source, a consultant, and the company to find out more.

NHS reform could give patients choice to seek private care

Population health is at the centre of a new NHS England reform that will give purchasing power to local, integrated health bodies across the UK. At first glance, the white paper points to less work for the private sector, but a new procurement system could tip it towards the system seen in Europe, where the local body often acts as a payor and the patient has a much wider choice of provider.

Penta to sell stake in hospital business; IMs out by March

CEE private equity firm Penta Investments is seeking a new investor for its hospital division, Penta Hospitals International (PHI), and aims to launch a process with investment memorandums (IMs) out by the end of February, investment director Václav Jirků tells HBI. He discusses the reason for the sale, including international expansion, and the current political turmoil surrounding Penta and its healthcare business.

Elsan to “refrain from sizeable acqusitions for 12-18 months” after C2S deal

Credit rating agency Moody's understands that France's largest for-profit acute hospital group Elsan will "refrain from sizeable debt-funded acquisitions such as Groupe C2S over the next 12 to 18 months and focus on bolt-on acquisitions," after downgrading its debt rating outlook to 'negative' following an increase in leverage from its the deal. We talk to Elsan and L.E.K. France.

Efficiency innovations becoming added-value for oxygen suppliers

Many oxygen suppliers have been continuously hostile to innovation that could make delivery more efficient, HBI hears. The pandemic has renewed attention on supply, pricing and patient outcomes leading to some to reassess the approach. HBI speaks to one medical device company that claims to save up to 80% of oxygen for an inpatient. 

Find Us